VANCOUVER, British Columbia, Jan. 03, 2018 -- Argentina Lithium & Energy Corp. (TSX-V:LIT) (FSE:OAY1) (WKN:A0RK7E) (OTC:PNXLF), “Argentina Lithium” or the “Company”) is pleased to provide an update with respect to the completion of its private placement (the “Private Placement”). This Private Placement was announced November 21, 2017 and completion of the 1st Tranche was announced on December 21, 2017. The Company anticipates closing the 2nd and final Tranche during the week of January 15, 2018.
The proceeds of the financing will be used for exploration programs on the Company’s projects in Argentina and for general working capital.
This financing is subject to regulatory approval and all securities to be issued pursuant to the financing are subject to a four-month hold period from the date of issue.
ON BEHALF OF THE BOARD
“Nikolaos Cacos”
_____________________________________
Nikolaos Cacos, President, CEO and Director
For further information please contact:
Corporate Communications
Tel: 1-604-687-1828
Toll-Free: 1-800-901-0058
Email: [email protected]
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.


Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
How Marco Pharma International Preserves German Homeopathic Traditions in America
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit
Air New Zealand Cabin Crew Strike Set for February 12–13 Amid Failed Talks
Petrobras Posts Record Oil Exports as Production Surge Fuels Global Expansion
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains
Ancora Holdings Builds $200M Stake in Warner Bros Discovery, Targets Netflix Asset Sale Plan
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates
SMIC Shares Slide Despite Strong AI-Driven Earnings as Margin Pressure Looms
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act
FTC Questions Apple News Over Alleged Bias Against Conservative Media
Russia Signals Further Restrictions on Telegram Amid Ongoing Regulatory Disputes
Boeing Reports Major Supply Chain Quality Improvements After Spirit AeroSystems Deal 



